Mislabelling means some patients could get wrong drug: Health Canada

OTTAWA - Health Canada is warning consumers who take the antidepressant Trazorel (50 mg) or the anti-nausea medication Cesamet (1 mg) of a mislabelling issue that may potentially result in patients getting the wrong medication.
The manufacturer of the two drugs, Valeant Canada, has received a report of one bottle in a shipment of Cesamet 1-mg capsules that was mislabelled as Trazorel 50-mg tablets. The company is working with distributors and pharmacists to recall the affected products.
Patients taking either of these medications should check their prescription bottles to ensure they contain the correct product. Trazorel 50 mg comes in round, peach-coloured tablets engraved with ICN T21. Cesamet 1 mg is sold in blue-and-white capsules with the number 3101 imprinted on the white part of the capsule.
Patients who have the wrong pills in their bottles should immediately contact their health-care professional and return the medication to their pharmacist.
Trazorel (trazodone hydrochloride) is indicated to treat depression but is sometimes prescribed to induce sleep. A patient taking Cesamet instead of Trazorel could expect to experience a worsening of his or her depression. Cesamet (nabilone) is used to treat nausea associated with chemotherapy.
Anyone who has been taking Trazorel instead of Cesamet would continue to experience nausea and vomiting. Valeant Canada says Trazorel is sold primarily in Saskatchewan, while Cesamet is sold across the country.
Consumers requiring more information about this advisory can contact Health Canada's public inquiries line at 613-957-2991, or toll-free at 1-866-225-0709.